IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,110,638 | -9.3% | 115,331 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $1,224,824 | +3.6% | 115,115 | +2.4% | 0.00% | -50.0% |
| Q1 2023 | $1,182,196 | -15.5% | 112,376 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $1,398,348 | +19.8% | 112,861 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,167,676 | +96.6% | 112,710 | +118.6% | 0.00% | +100.0% |
| Q2 2022 | $594,000 | -17.4% | 51,567 | -9.7% | 0.00% | 0.0% |
| Q1 2022 | $719,000 | +10.3% | 57,128 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $652,000 | -13.9% | 55,904 | -3.7% | 0.00% | -50.0% |
| Q3 2021 | $757,000 | -2.4% | 58,023 | -3.8% | 0.00% | 0.0% |
| Q2 2021 | $776,000 | -3.1% | 60,346 | -15.8% | 0.00% | 0.0% |
| Q1 2021 | $801,000 | +1.4% | 71,661 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $790,000 | +61.6% | 69,397 | +27.6% | 0.00% | +100.0% |
| Q3 2020 | $489,000 | -12.8% | 54,381 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $561,000 | -27.7% | 54,381 | -29.3% | 0.00% | -50.0% |
| Q1 2020 | $776,000 | -22.7% | 76,914 | +2.0% | 0.00% | 0.0% |
| Q4 2019 | $1,004,000 | +96.9% | 75,396 | +26.9% | 0.00% | +100.0% |
| Q3 2019 | $510,000 | -21.5% | 59,415 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $650,000 | -17.2% | 59,415 | +2.4% | 0.00% | -50.0% |
| Q1 2019 | $785,000 | +30.6% | 58,012 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $601,000 | -41.6% | 58,012 | +4.0% | 0.00% | -50.0% |
| Q3 2018 | $1,029,000 | -3.5% | 55,769 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,066,000 | +16.1% | 55,769 | -6.3% | 0.00% | 0.0% |
| Q1 2018 | $918,000 | 0.0% | 59,506 | -2.9% | 0.00% | 0.0% |
| Q4 2017 | $918,000 | -7.7% | 61,273 | -2.9% | 0.00% | 0.0% |
| Q3 2017 | $995,000 | -16.5% | 63,091 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $1,191,000 | +23.5% | 63,091 | +11.6% | 0.00% | +50.0% |
| Q1 2017 | $964,000 | +11.6% | 56,535 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $864,000 | -3.8% | 56,535 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $898,000 | +21.5% | 56,535 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $739,000 | +19.6% | 56,535 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $618,000 | -5.6% | 56,535 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $655,000 | +11.2% | 56,535 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $589,000 | -25.3% | 56,535 | -13.5% | 0.00% | -50.0% |
| Q2 2015 | $788,000 | -24.7% | 65,373 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,046,000 | +4.4% | 65,373 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,002,000 | +18.3% | 65,373 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $847,000 | -15.5% | 65,373 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,002,000 | +29.3% | 65,373 | +3.9% | 0.00% | 0.0% |
| Q1 2014 | $775,000 | +6.2% | 62,906 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $730,000 | +11.3% | 62,906 | +13.6% | 0.00% | 0.0% |
| Q3 2013 | $656,000 | +19.1% | 55,392 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $551,000 | – | 55,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |